A study to determine the dose of dexmedetomidine that can effectively prevent shivering after cesarean section with minimal side effects
Not Applicable
Completed
- Conditions
- Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium
- Registration Number
- CTRI/2021/11/037798
- Lead Sponsor
- Koldinne Jagadeeswara Reddy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
• Parturients with BMI 18-35kg/m2 undergoing
caesarean delivery under spinal anaesthesia
Exclusion Criteria
• Patients refusal
• Allergy and contraindication to the study drug
(Dexmedetomidine)
• Patients belonging to ASA grade III and above.
• BMI <18 to > 35kg/m2
• Twin / multiple pregnancy
• History of chronic nausea or itching /pruritis
during pregnancy
• Psychiatric and mentally retarded patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the efficacy of two different doses of IV dexmedetomidine i.e., 10µg and 20µg for reducing shivering in women undergoing caesarean delivery under spinal anaesthesia based on patient and observer rated scores taken at 30 and 60 min after arrival in the PACU compared with that of baselineTimepoint: 30 minutes and 60 minutes
- Secondary Outcome Measures
Name Time Method To study the side effects of dexmedetomidine (if any) like nausea/vomiting, pruritus, dry mouth and sedation postoperatively in the PACU for 60 min.Timepoint: for 60 minutes continuously